17
Modeling model organisms in model systems? The case for Diphtheria Dr Paul A Hoskisson, Institute of Pharmacy and Biomedical Sciences, University of Strathclyde Email: [email protected]

Modeling model organisms in model systems? The case for Diphtheria Dr Paul A Hoskisson, Institute of Pharmacy and Biomedical Sciences, University of Strathclyde

Embed Size (px)

Citation preview

Page 1: Modeling model organisms in model systems? The case for Diphtheria Dr Paul A Hoskisson, Institute of Pharmacy and Biomedical Sciences, University of Strathclyde

Modeling model organisms in model systems? The case for

Diphtheria

Dr Paul A Hoskisson,Institute of Pharmacy and Biomedical Sciences,

University of StrathclydeEmail: [email protected]

Page 2: Modeling model organisms in model systems? The case for Diphtheria Dr Paul A Hoskisson, Institute of Pharmacy and Biomedical Sciences, University of Strathclyde

Corynebacterium diphtheriae• Aetiological agent of Diphtheria – phage conversion

• Controlled by vaccination since 1945

• Still causes ~5000 deaths per year worldwide• Resurgence in Eastern Europe in mid-1990’s• Emergence of non-toxigenic disease causing strains

Page 3: Modeling model organisms in model systems? The case for Diphtheria Dr Paul A Hoskisson, Institute of Pharmacy and Biomedical Sciences, University of Strathclyde

Non-toxigenic C. diphtheriae• Causes persistent sore throats, pharyngitis,

deep tissue infections, osteomyelitits, endocarditis in immuno-compromised

• Increasing infections in immuno-competent patients

• Can be invasive

Page 4: Modeling model organisms in model systems? The case for Diphtheria Dr Paul A Hoskisson, Institute of Pharmacy and Biomedical Sciences, University of Strathclyde

Why are we interested in non-toxigenic C. diphtheriae?

• Increasing numbers of cases in UK – no explanation why• We know little about colonisation, persistence and invasion in hosts,

carriage levels etc• Unusual antibiotic resistances• We know little about virulence factors outside of the toxin• We know little about genome and population structure in C. diphtheriae

Page 5: Modeling model organisms in model systems? The case for Diphtheria Dr Paul A Hoskisson, Institute of Pharmacy and Biomedical Sciences, University of Strathclyde

Why are we interested in non-toxigenic C. diphtheriae?

• Increasing numbers of cases, limited testing, 27 case in Grampian region in the last 5 years

1990 1992 1994 1996 1998 2000 2002 2004 2006

0

50

100

150

200

250

300

Nu

mb

er

of

lab

ora

tory

co

nfir

me

d c

ase

s

Year

Toxigenic Nontoxigen

Page 6: Modeling model organisms in model systems? The case for Diphtheria Dr Paul A Hoskisson, Institute of Pharmacy and Biomedical Sciences, University of Strathclyde

How are we approaching this problem?

• Identification of novel virulence factors– Transposon mutagenesis– Promoter-probe libraries– Gene dosage libraries

• Understanding colonisation (adhesion & Invasion)– Novel tractable models

• Understanding population and genome structure

Page 7: Modeling model organisms in model systems? The case for Diphtheria Dr Paul A Hoskisson, Institute of Pharmacy and Biomedical Sciences, University of Strathclyde

Our model system – C. diphtheriae- Caenorhabditis

elegans model

• 3 R’s

• Genetically tractable

• Treatment model/ drug screening model

Page 8: Modeling model organisms in model systems? The case for Diphtheria Dr Paul A Hoskisson, Institute of Pharmacy and Biomedical Sciences, University of Strathclyde

Optimisation of the worm model

Time (h)

% S

urv

ival

of

C. e

leg

ans

po

st

infe

ctio

n

0 20 40 60 80 100 120

0

1x107

2x107

3x107

4x107

5x107

6x107

7x107

8x107

CF

U p

er

wo

rm

Time (h)

Bacterial load increases over time

Worm survival is impaired following infection

C. diphtheriae localise to the pharynx- adhesion and persistence in non-invasive strains

Page 9: Modeling model organisms in model systems? The case for Diphtheria Dr Paul A Hoskisson, Institute of Pharmacy and Biomedical Sciences, University of Strathclyde

Optimisation of the worm model: Infection of C. elegans with invasive and non

invasive C. diptheriae strains

C. elegans infected with invasive C. diptheriae (ISS3319) – 2 d

C. elegans infected with non-invasive C. diptheriae (DSM43988) – 2 d

Page 10: Modeling model organisms in model systems? The case for Diphtheria Dr Paul A Hoskisson, Institute of Pharmacy and Biomedical Sciences, University of Strathclyde

0 20 40 60 80 100 12060

65

70

75

80

85

90

95

100

Wor

m s

urvi

val f

ollo

win

g in

fect

ion

(%)

Time (h)

NonInvWT Clone16 Clone18 Clone21 Clone28

Time (h)

% S

urv

ival

of

C. e

leg

ans

po

st in

fect

ion

Screening libraries of multicopy vectors

• Genomic fragments of DSM43988 (~3Kbp) in pNV18

Incubated with C. elegans and survival monitored

Amenable to high-throughput screens

Page 11: Modeling model organisms in model systems? The case for Diphtheria Dr Paul A Hoskisson, Institute of Pharmacy and Biomedical Sciences, University of Strathclyde

Acanthamoeba polyphaga can be used to assay bacterial virulence

• A. polyphaga is a free-living amoeba found in soil and water

• Associations between Acanthamoeba and bacteria are known in the environment– M. ulcerans – Buruli Ulcer– Legionella – Microbial gymnasia

• Used as a macrophage model- similar survival strategies

Avirulent strain

Virulent strain

Media concentration

100-10%

Amoebae numbers

10,000-10

Page 12: Modeling model organisms in model systems? The case for Diphtheria Dr Paul A Hoskisson, Institute of Pharmacy and Biomedical Sciences, University of Strathclyde

Amoeba model allows the study of adhesion and invasion

Amoebae (Brightfield)

Fluorescent C. dip with amoebae

Merged C. dip with amoebae

DSM43988 – non-invasive

ISS3319 – ‘invasive’ Aberdeen strain 1 –invasive

Page 13: Modeling model organisms in model systems? The case for Diphtheria Dr Paul A Hoskisson, Institute of Pharmacy and Biomedical Sciences, University of Strathclyde

Attachment and invasion of D562 mammalian cells is

variable too

Page 14: Modeling model organisms in model systems? The case for Diphtheria Dr Paul A Hoskisson, Institute of Pharmacy and Biomedical Sciences, University of Strathclyde

Difference in strains• Strains supposed to be highly similar –

pathogenicity differences due to the presence of bacteriophage

• View is changing – microarray studies show at least 30 loci different in an outbreak strain vs vaccine strain

• Recent MLST analysis shows high levels of strain variation

• Phenotypic variation –inability to ferment sucrose diagnostic

Page 15: Modeling model organisms in model systems? The case for Diphtheria Dr Paul A Hoskisson, Institute of Pharmacy and Biomedical Sciences, University of Strathclyde

Variation in cell surfaces

Page 16: Modeling model organisms in model systems? The case for Diphtheria Dr Paul A Hoskisson, Institute of Pharmacy and Biomedical Sciences, University of Strathclyde

What would we like to do?• Cells in C. elegans all mapped and the

developmental process

• Genetic tools available for C. diphtheriae– e.g. Toll mutant

• Lends its self perfectly to study colonisation, persistence, invasion and disease progression

• Amenable to high throughput screens

• Develop models of infection in models- mathematical? Exploit image processing technology?

Page 17: Modeling model organisms in model systems? The case for Diphtheria Dr Paul A Hoskisson, Institute of Pharmacy and Biomedical Sciences, University of Strathclyde

Acknowledgements• Ashleigh McKenzie• Teresa Baltazar• Dr Alison Hunt • Dr Rebecca Edwards

• Prof Andreas Burkovski – University of Erlangen– Andrea Bischof– Sabine Rodel

Dr Maria Sanchez-Contreras – University of Bath

Dr Jonathon Pettit & Dr Neale Harrison – University of AberdeenCaenorhabditis Genetic Centre – University of Minnesota

Society for General Microbiology